Recorded Chinese product: 利福平滴眼液利福平滴眼液
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 合肥利民制药有限公司Chinese legal name: 合肥利民制药有限公司
主要成分Active Ingredients
- 利福平Lifu Ping
药物知识说明
利福平是一种在国家药监局注册认定的药品。该药品含有利福平-a99fbd4c等成分。
该药品关联的活性成分包括：利福平Lifu Ping。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：合肥利民制药有限公司Chinese legal name: 合肥利民制药有限公司。
您可以探索含有相同成分的其他药品：利福平-a99fbd4c成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 利福平滴眼液) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 利福平Lifu Ping.
Manufacturers recorded for this product: 合肥利民制药有限公司Chinese legal name: 合肥利民制药有限公司.
Explore other medicines containing the same ingredient: 利福平 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 利福平滴眼液Recorded Chinese product: 利福平滴眼液
- 剂型Dosage form: 滴眼剂Eye drops
- 规格Specification: 每片含利福平5mg,缓冲液10mlRecorded Chinese composition: 每片含利福平5mg,缓冲液10ml
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 合肥利民制药有限公司Chinese legal name: 合肥利民制药有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H34022128
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H34022128
Manufacturer
Chinese legal name: 合肥利民制药有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
Keep sealed.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H34022128
生产企业
合肥利民制药有限公司(国产)
适应症
本品用于沙眼、结膜炎、角膜炎等。
用法用量
滴眼，一次1～2滴，一日4～6次。使用前，请蒋滴丸放入缓冲液中，振摇，使完全溶解。
不良反应
1.畏寒、呼吸困难、头昏、发热、头痛、泪液呈橘红色或红棕色等。
2.尚可引起皮肤发红或皮疹(过敏反应)、瘙痒等症状。
禁忌
1.本品过敏者禁用。
2.严重肝功能不全者禁用。
3.胆道阻塞患者禁用。
注意事项
1.对诊断的干扰：
(1)可引起直接抗球蛋白试验(Coombs试验)阳性。
(2)干扰血清叶酸浓度测定和血清维生素B12浓度测定结果。
(3)可使磺溴酞钠试验滞留出现假阳性。
(4)可干扰利用分光光度计或颜色改变而进行的各项尿液分析试验的结果。
(5)可使血液尿素氮、血清碱性磷酸酶、血清丙氨酸氨基转移酶、门冬氨酸氨基转移酶、血清胆红素及血清尿酸浓度测定结果增高。
2.酒精中毒，肝功能损害者慎用，一般肝病患者慎用。
3.利福平可能引起白细胞和血小板减少，并导致齿龈出血和感染，伤口愈合延迟等。此时应避免拔牙手术 ，并注意口腔卫生，刷牙及剔牙均需慎重，直至血象恢复正常。
贮藏
密封。
规格
每片含利福平5mg,缓冲液10ml
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.